It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
44 U.S. states accuse big pharma of price fixing generics market
-
Gelomyrtol, Federal Court of Justice (Bundesgerichtshof), 23 October 2012
-
Italy and Unified Patent Court sign agreement on Milan central division
-
DNA Mixture Analysis, European Patent Office (Appeals Court), 19 February 2013
-
Patent case: Filtern digitaler Videobilder, Germany
-
Effective Measures for Securing Evidence have been Instituted
-
ILO Administrative Tribunal dismisses complaints against EPO president
-
Breaking News: Board of Appeal finds that Acetic Acid is no Inorganic Acid.
-
More on escitalopram PI cases in Denmark
-
EPO: T1938/09, European Patent Office (EPO), Board of Appeal, ECLI:EP:BA:2014:T193809.20141002, 2 November 2014